Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
Financials
Financial year 2025
SAINT-REMY BIOMEDICALS from Grez-Doiceau, company number BE0810927522, closed financial year 2025 with a result of € 9,473 after tax. For that financial year SAINT-REMY BIOMEDICALS recorded a gross margin of € 13,125 and equity of € -44,890. Compared with financial year 2024, the result moved from € 13,700 to € 9,473. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.
€ -44,890
▲ € 9,473 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,473
▼ 31% vs 2024
Profit after tax over the fiscal year.
€ 36,954
▲ € 31,616 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -63,490.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,135
▲ € 3,664 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,057
▲ € 2,776 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -4,040 | € 10,734 | € 14,566 | € 13,125 | ▼ 10% |
| Profit after taxes | € -4,664 | € 10,045 | € 13,700 | € 9,473 | ▼ 31% |
| Equity | € -78,107 | € -68,062 | € -54,362 | € -44,890 | ▲ € 9,473 |
| Total debts | € 99,485 | € 109,268 | € 103,219 | € 100,363 | ▼ 3% |
| Cash | € 2,859 | € 22,687 | € 5,338 | € 36,954 | ▲ € 31,616 |
| Retained profit | € -96,707 | € -86,662 | € -72,962 | € -63,490 | ▲ € 9,472 |
| Balance sheet total | € 21,378 | € 41,205 | € 48,857 | € 55,473 | ▲ 14% |
By gross margin, SAINT-REMY BIOMEDICALS ranks 32nd of 46 companies with main activity “Speur- en ontwikkelingswerk op biotechnologisch gebied” in Walloon Brabant that publish figures (fiscal year 2025).
Key figures of SAINT-REMY BIOMEDICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
Ask about SAINT-REMY BIOMEDICALS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to SAINT-REMY BIOMEDICALS?
What happened at SAINT-REMY BIOMEDICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,473 (▼ 31% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 4,664 loss in 2022 to € 9,473 profit in 2025.
Paid € 3,615 in corporate taxes since 2022.
Best year ever: 2024, with € 13,700 profit.
Management
Behind SAINT-REMY BIOMEDICALS is Jean-Marie SAINT-REMY. Jean-Marie SAINT-REMY is also behind THALIA.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Rue du Lambais 79
1390 Grez-Doiceau
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Walloon Brabant
Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 62 active companies in Walloon Brabant, largest first.
€ 8.6 million revenue · 2025 · Mont-Saint-Guibert
€ 5 million gross margin · 2025 · Ottignies-Louvain-la-Neuve
€ 3.2 million gross margin · 2025 · Braine-l'Alleud
€ 2.1 million gross margin · 2025 · Jodoigne
€ 2.1 million gross margin · 2025 · Ottignies-Louvain-la-Neuve
€ 1.6 million gross margin · 2025 · Mont-Saint-Guibert
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Saint-Remy Jean-Marie(oprichter) 100%
Details
- Company number
- 0810.927.522
- VAT number
- BE 0810.927.522
- Registered office
- Rue du Lambais 79, 1390 Grez-Doiceau
- Names & denominations
- SAINT-REMY BIOMEDICALS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 March 2009
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Overige gespecialiseerde wetenschappelijke en technische activiteiten